Analysis of the clinical effect size after glucagon-like peptide-1 receptor agonist therapy on the functional activity of the intestinal microbiota, morpho-metabolic indicators and the level of psychological distress in type 2 diabetic patients

Epigenetic modifications: a valid mechanism for realizing vascular complications and metabolic memory in diabetes?

Expression of M2-macrophages, mTOR-positive cells and VEGF within fibroepithelial skin tags in patients with type 2 metabolic syndrome